Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management.
Fatima A, Rasool S, Devi S, Talha M, Waqar F, Nasir M, Khan MR, Ibne Ali Jaffari SM, Haider A, Shah SU, Sapna F, Varrassi G, Khatri M, Kumar S, Mohamad T.
Fatima A, et al. Among authors: devi s.
Cureus. 2023 Sep 30;15(9):e46243. doi: 10.7759/cureus.46243. eCollection 2023 Sep.
Cureus. 2023.
PMID: 37908957
Free PMC article.
Review.